Mangoceuticals Inc
NASDAQ:MGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Phihong Technology Co Ltd
TWSE:2457
|
TW |
|
Makiya Co Ltd
TSE:9890
|
JP |
|
B
|
Bor Seker AS
IST:BORSK.E
|
TR |
|
G
|
Gokaldas Exports Ltd
BSE:532630
|
IN |
Mangoceuticals Inc
Other
Mangoceuticals Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
Other
$1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
Other
-$137m
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
10%
|
|
Mangoceuticals Inc
Glance View
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.
See Also
What is Mangoceuticals Inc's Other?
Other
1.2m
USD
Based on the financial report for Dec 31, 2025, Mangoceuticals Inc's Other amounts to 1.2m USD.
